Variant report
Variant | esv3389552 |
---|---|
Chromosome Location | chr8:54266649-54268872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576627875 | chr8:54266669-54266670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114355162 | chr8:54266670-54266671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547737087 | chr8:54266681-54266682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146880124 | chr8:54266703-54266704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372828007 | chr8:54266708-54266709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112662231 | chr8:54266725-54266726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572688240 | chr8:54266788-54266789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541405514 | chr8:54266797-54266798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533652672 | chr8:54266814-54266815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564802093 | chr8:54266873-54266874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116696919 | chr8:54266890-54266891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200267603 | chr8:54266930-54266931 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571135717 | chr8:54266942-54266943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191924507 | chr8:54266971-54266972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114419355 | chr8:54266992-54266993 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7011944 | chr8:54267021-54267022 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs531332082 | chr8:54267077-54267078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184065345 | chr8:54267122-54267123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs60684856 | chr8:54267222-54267223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs58836513 | chr8:54267229-54267230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550393602 | chr8:54267243-54267244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376335103 | chr8:54267244-54267245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200513217 | chr8:54267246-54267247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527580983 | chr8:54267267-54267268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535909813 | chr8:54267292-54267293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7012435 | chr8:54267298-54267299 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs555736855 | chr8:54267357-54267358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570733896 | chr8:54267359-54267360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35422785 | chr8:54267360-54267361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35358140 | chr8:54267363-54267364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539812033 | chr8:54267373-54267374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111912732 | chr8:54267387-54267388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565908876 | chr8:54267390-54267391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111677890 | chr8:54267415-54267416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559440088 | chr8:54267427-54267428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113051450 | chr8:54267495-54267496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570145228 | chr8:54267517-54267518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535990695 | chr8:54267518-54267519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145463386 | chr8:54267525-54267526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572499077 | chr8:54267550-54267551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs57049877 | chr8:54267663-54267664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs58961580 | chr8:54267667-54267668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145595522 | chr8:54267697-54267698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555085914 | chr8:54267747-54267748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369335716 | chr8:54267748-54267749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577938848 | chr8:54267805-54267806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192747022 | chr8:54267817-54267818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562178564 | chr8:54267820-54267821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531296157 | chr8:54267850-54267851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs28497511 | chr8:54267872-54267873 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:54264800-54266800 | Enhancers | Hela-S3 | cervix |
2 | chr8:54266200-54268600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr8:54266400-54266800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:54266800-54267000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr8:54267000-54269200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:54268600-54270200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr8:54268800-54269800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |